The PennZone

PHILADELPHIA, April 8, 2024 ~ In a recent announcement, Alternative Investment Exchange (AIX) revealed its new partnership with Concorde Investment Services. This collaboration will utilize AIX's innovative technology to automate alternative investing processes for Concorde, its advisors, and their clients.

Concorde, a renowned leader in the alternative investments industry, is based in Ann Arbor, Michigan and operates as a Registered Investment Advisor (RIA), full-service broker-dealer, and insurer. This partnership is significant for AIX as it allows them to work with a well-respected company in the field.

One of the main benefits of this partnership for AIX is the use of their data-driven technology. This technology will increase efficiency and reduce risk for both Concorde and its clients. One major advantage is the significant reduction of Not-In-Good-Order (NIGO) errors, which can often hinder investments in alternatives. NIGO errors occur when investment documents are incorrect, outdated or lack vital information such as signatures.

According to Danielle Delongchamp, President and CEO of Concorde, this partnership with AIX will provide their representatives with a streamlined technology solution to meet each client's unique investing needs. She also highlighted AIX's ability to reduce NIGO errors significantly and its user-friendly interface with digital signature and straight-through processing. Additionally, she mentioned that AIX's capability to deliver private placement memorandums (PPMs) electronically was another exciting feature.

More on The PennZone

• French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
• LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
• Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
• STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
• Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice

Brad West, Chief Operating Officer of AIX expressed his enthusiasm about working with an alternative investments leader like Concorde. He believes that this partnership showcases AIX's success in automating the alternatives investing process. He also looks forward to collaborating with the Concorde team to serve their loyal clients.

AIX's platform functions as a workflow management solution that automatically populates forms and relevant systems with data. This streamlines the investing process for advisors, clients, sponsors, custodial parties, home offices, and compliance. The platform supports the full-capital alternatives life cycle, including data rooms and electronic delivery of offering materials, all-digital transactions, and post-trade account monitoring.

Overall, this partnership between AIX and Concorde is a significant step towards revolutionizing the alternative investments industry. With AIX's advanced technology and Concorde's expertise in the field, clients can expect a more efficient and streamlined investing experience.

---

Show All News | Disclaimer | Report Violation